Concomitantly, plasma ghrelin was evaluated in a study of acotiamide for FD patients, which revealed that pharmaceutical intervention significantly increased ghrelin secreting and improved impaired gastric emptying [31]. The gene discussed is GHRL; the disease is Fabry disease.